Onderneming TapImmune Inc Nasdaq
Aandelen
US8760334081
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Immunotherapies and Innovative Peptide-Based Vaccines
100,0
%
| 9 | 100,0 % | 3 | 100,0 % | -63,26% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 9 | 100,0 % | 3 | 100,0 % | -63,26% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Juan F. Vera
CEO | Chief Executive Officer | 44 | 17-10-18 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-11-19 |
Chief Tech/Sci/R&D Officer | 51 | 23-10-18 | |
Chief Administrative Officer | - | 01-09-15 | |
John Wilson
BRD | Director/Board Member | 64 | - |
Edmund Cheung
HRO | Human Resources Officer | - | 01-01-21 |
Nadia Agopyan
LAW | General Counsel | 62 | 15-08-19 |
General Counsel | 67 | 23-10-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 63 | 17-10-18 | |
Steven Elms
BRD | Director/Board Member | 60 | 06-08-19 |
Katharine Knobil
BRD | Director/Board Member | 60 | 08-12-21 |
John Wilson
BRD | Director/Board Member | 64 | - |
Juan F. Vera
CEO | Chief Executive Officer | 44 | 17-10-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 8 913 490 | 7 830 252 ( 87,85 %) | 0 | 87,85 % |
Bedrijfsgegevens
Marker Therapeutics, Inc.
4551 Kennedy Commerce Drive
77032, Houston
+713 400 6400
http://www.markertherapeutics.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,69% | 47,9 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,7 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |